Melatonin: Reducing intracellular hostilities

Endocrinologist

Volumn 14, Issue 4, 2004, Pages 222-228

  Reiter, Russel J ^a   Tan, Dun Xian ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Antioxidant; Free radical scavenger; Heart attack; Melatonin; Neurodegenerative diseases; Stroke

Indexed keywords

MELATONIN; REACTIVE OXYGEN METABOLITE;

AGING; ALZHEIMER DISEASE; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; CELL DEATH; CELL PROTECTION; DIET; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG MECHANISM; EXPERIMENTAL MODEL; EYE DISEASE; HEART DISEASE; HEART INFARCTION; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; KIDNEY DISEASE; LUNG DISEASE; NEUROPHARMACOLOGY; NEWBORN HYPOXIA; NONHUMAN; OXIDATIVE STRESS; PARKINSONISM; RESPIRATORY DISTRESS SYNDROME; REVIEW; SEPSIS; SKIN DISEASE; STROKE; TOXICITY;

EID: 3242720530     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ten.0000134935.40718.8d     Document Type: Review

References (31)

1. Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrine Res. 1991;12:151-180.
2. Tan DX, Manchester LC, Hardeland R, et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid and an antioxidant vitamin. J Pineal Res. 2003;34:75-78.
3. Reiter RJ, Tan DX, Manchester LC, et al. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys. 2001;34:237-256.
4. Cheung RTF. The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. J Pineal Res. 2003;34:153-160.
5. Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol. 1998;56:359-384.
6. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, 3rd ed. New York: Oxford University Press; 2000.
7. Harman D. Aging: prospects for further increases in the functional life span. Aging. 1994;17:119-146.
8. Tan DX, Chen LD, Poeggeler B, et al. Melatonin: a potent, endogenous hydroxy radical scavenger. Endocrine J. 1993;1:57-60.
9. Allegra M, Reiter RJ, Tan DX, et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res. 2003;34:1-10.
10. Rodriguez C, Mayo JC, Sainz RM, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res. 2004;36:1-9.
11. Tan DX, Reiter RJ, Manchester LC, et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Topics Med Chem. 2002;2:181-199.
12. Urata Y, Honma S, Goto S, et al. Melatonin induces γ- glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells. Free Radical Biol Med. 1999;27:838-847.
13. Reiter RJ, Sainz RM, Lopez-Burillo S, et al. Melatonin ameliorates neurologic damage and neurophysiologic deficits in experimental models of stroke. Ann NY Acad Sci. 2003;993:35-47.
14. Torii K, Uneyama H, Nishino H, et al. Melatonin suppresses cerebral edema caused by middle cerebral artery occlusion/reperfusion in rats assessed by magnetic resonance imaging. J Pineal Res. 2004;36:18-24.
15. Reiter RJ, Tan DX. Melatonin: a novel protective agent against oxidative injury of the ischemia/reperfused heart. Cardiovasc Res. 2003;58:10-19.
16. Dobsak P, Siegelova J, Eicher JC, et al. Melatonin protects against ischemia-reperfusion injury and inhibits apoptosis in isolated working heart. Pathophysiology. 2003;9:179-187.
17. Fulia F, Gitto E, Cuzzocrea S, et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res. 2001;31:343-349.
18. Pappolla MA, Reiter RJ, Bryant-Thomas TK, et al. Oxidative mediated neurodegeneration in Alzheimer's disease: melatonin and related antioxidants as neuroprotective agents. Curr Med Chem. 2003;3:233-243.
19. Pappolla MA, Sos M, Beck RJ, et al. Melatonin prevents death of neuroblastoma cells exposed to Alzheimer amyloid peptide. J Neurosci. 1997;17:1683-1690.
20. Wang DL, Ling ZQ, Cao FY, et al. Melatonin attenuates isoproterenol-induced protein kinase A overactivation and tau hyperphosphorylation in rat brain. J Pineal Res. 2004; in press.
21. Matsubara E, Bryant-Thomas T, Quinto JP, et al. Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. J Neurochem. 2003;85:1101-1108.
22. Reiter RJ, Acuña-Castroviejo D, Tan DX, et al. Free radical mediated molecular damage: mechanisms of melatonin's protective actions in the central nervous system. Ann NY Acad Sci. 2001;939:200-215.
23. Reiter RJ, Tan DX, Manchester LC, et al. Melatonin reduces oxidative damage and promotes mitochondrial respiration: role of oxidative stress. Ann NY Acad Sci. 2002;959:238-250.
24. Antolin I, Mayo JC, Sainz RM, et al. Protective effect of melatonin in a chronic experimental model of Parkinson's disease. Brain Res. 2002;943:163-173.
25. Jou MJ, Peng TI, Reiter RJ, et al. Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J Pineal Res. 2004; in press.
26. Sewerynek E, Melchiorri D, Chen LD, et al. Melatonin reduces both basal and bacterial lipopolysaccharide-induced lipid peroxidation. Free Radical Biol Med. 1995;19:903-909.
27. Gitto E, Karbownik M, Reiter RJ, et al. Effects of melatonin in septic newborns. Pediatr Res. 2001;50:756-760.
28. Gitto E, Reiter RJ, Amodio A, et al. Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin. J Pineal Res. 2004;36:250-255.
29. Reiter RJ. Oxygen radical detoxification processes during aging: the functional importance of melatonin. Aging Exp Clin Res. 1995;7:340-351.
30. Jan JE, Hamilton D, Seward N, et al. Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders. J Pineal Res. 2000;29:34-39.
31. Jahnke G, Marr M, Myers C, et al. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Res. 1999;50:271-274.